Overview

Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest Wall

Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
This is a research study to evaluate the effects of ThermoDox in combination with therapeutic heating of the chest wall in the treatment of recurrent regional breast cancer. The purpose of this study is to evaluate the bioequivalence of ThermoDox and measure efficacy in recurrent chest wall patients.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Celsion